Correction to: Cell Research https://doi.org/10.1038/s41422-020-00459-5, published online 20 January 2021
The licence information was missing from this article and should have been CC-BY.
The original article has been corrected.
About this article
Cite this article
Hoffmann, M., Jin, Y. & Pöhlmann, S. Publisher Correction: Dalbavancin: novel candidate for COVID-19 treatment. Cell Res (2022). https://doi.org/10.1038/s41422-022-00713-y